Archives for posts with tag: drug resistance

Some cancer treatments target certain proteins in cancer cells to stop the cancer cells growing, dividing and spreading. These targeted therapies have dramatically improved the outcomes of many people with cancer, including those with breast cancer.

Unfortunately, patients can develop resistance to targeted therapies and then the drugs no longer work as they should.

This is a major clinical problem for breast cancer patients, so new approaches to overcome it are desperately needed.

Read the rest of this entry »

Advertisements

Targeted cancer therapies – drugs that interfere with specific molecules to block cancer growth and spread – have revolutionised the treatment of certain types of tumour. But tumour cells can become resistant to these therapies, and so patients no longer respond to the drugs.

Herceptin binding to HER2 receptors on breast cancer cells // Image by Adam Byron

Herceptin binding to HER2 receptors on breast cancer cells

Read the rest of this entry »